Products for Research Use Only

Fasudil

CAT: 0804-HY-10341A-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10341A-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fasudil (HA-1077; AT877) is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil is also a potent Ca2+ channel antagonist and vasodilator[1][2][3].
CAS Number
103745-39-7
Product Name Alternative
HA-1077; AT877
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Calcium Channel; PKA; PKC; ROCK
Type
Reference compound
Related Pathways
Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Membrane Transporter/Ion Channel; Neuronal Signaling; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fasudil.html
Purity
99.91
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=S(C1=CC=CC2=C1C=CN=C2)(N3CCNCCC3)=O
Molecular Formula
C14H17N3O2S
Molecular Weight
291.37
Precautions
H302, H315, H319, H335
References & Citations
[1]Chen M, et al. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? Expert Opin Investig Drugs. 2013 Apr;22 (4) :537-50.|[2]Huang XN, et al. The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cordbarrier following experimental autoimmune encephalomyelitis. J Neuroimmunol. 2011 Oct 28;239 (1-2) :61-7.|[3]Uehata M, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997 Oct 30;389 (6654) :990-4.|[4]Fukushima M, et al. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 2005 Aug;25 (4) :829-38.|[5]Zhang J, et al. Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clin Chim Acta. 2009 Mar;401 (1-2) :76-80.|[6]Sun X, et al. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006 Nov;180 (1-2) :126-34. Epub 2006 Sep 22.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
PKA; PKC; ROCK1; ROCK2
Citation 01
Adipocyte. 2019 Dec;8 (1) :114-124. |Br J Cancer. 2023 May;128 (10) :1941-1954.|Cell Signal. 2026 Feb:138:112275.|Clin Transl Med. 2022 Jul;12 (7) :e961.|Clin Transl Med. 2022 Oct;12 (10) :e1036.|Inflammopharmacology. 2023 Aug;31 (4) :2037-2047.|Int J Biol Sci. 2024 Jan 12;20 (3) :897-915.|J Exp Clin Cancer Res. 2020 Jun 16;39 (1) :113.|J Pharm Pharmacol. 2021 Jul 7;73 (8) :1118-1127.|Neural Regen Res. 2021 Dec;16 (12) :2512-2520.|Sci Transl Med. 2018 Jul 18;10 (450) :eaaq1093.|SSRN. 2023 Feb 24.|Aging Cell. 2024 Jun 2:e14209.|Aging Cell. 2025 Jan;24 (1) :e14366.|Biochem Pharmacol. 2025 Apr 8:116933.|Biomed Rep. 2015 May;3 (3) :361-364. |Cell Mol Immunol. 2023 Apr;20 (4) :351-364.|Cell Stem Cell. 2025 Apr 3;32 (4) :581-597.e11.|Diabetol Metab Syndr. 2025 Oct 3;17 (1) :374.|Eur J Pharmacol. 2024 May 13:975:176640.|J Cereb Blood Flow Metab. 2025 Jun;45 (6) :1191-1202.|Metab Brain Dis. 2025 Jan 7;40 (1) :91.|NPJ Precis Oncol. 2025 Nov 26;9 (1) :391.|Sci Rep. 2018 Feb 6;8 (1) :2477. |Transl Neurosci. 2020 Apr 20;11 (1) :75-86.

Popular Products